Skip to main content

and
  1. Article

    Open Access

    Bayesian risk prediction model for colorectal cancer mortality through integration of clinicopathologic and genomic data

    Routine tumor-node-metastasis (TNM) staging of colorectal cancer is imperfect in predicting survival due to tumor pathobiological heterogeneity and imprecise assessment of tumor spread. We leveraged Bayesian a...

    Melissa Zhao, Mai Chan Lau, Koichiro Haruki, Juha P. Väyrynen in npj Precision Oncology (2023)

  2. Article

    Open Access

    Spatially resolved multimarker evaluation of CD274 (PD-L1)/PDCD1 (PD-1) immune checkpoint expression and macrophage polarisation in colorectal cancer

    The CD274 (PD-L1)/PDCD1 (PD-1) immune checkpoint interaction may promote cancer progression, but the expression patterns and prognostic significance of PD-L1 and PD-1 in the colorectal cancer microenvironment ...

    Hanna Elomaa, Maarit Ahtiainen, Sara A. Väyrynen, Shuji Ogino in British Journal of Cancer (2023)

  3. No Access

    Living Reference Work Entry In depth

    Spatial Technologies: A Game Changer for Studying the Tumor Microenvironment

    Traditional immunohistochemistry (IHC) has long been considered the “gold standard” for tissue pathology diagnosis. However, the diagnostic and prognostic value of this technique is limited by a number of fact...

    Ren Yuan LEE, Mai Chan LAU, Denise GOH, Felicia WEE in Handbook of Cancer and Immunology

  4. No Access

    Living Reference Work Entry In depth

    The Hurdle of Precision Medicine in Cancer Immunotherapy: Personalization Now or Then?

    Moving away from the generic treatment for all cancer, precision medicine provides a targeted therapy based on the different profile presented. Since the signing of Precision Medicine Initiative by the then US...

    Joseph Jun Quan Ng, Denise Goh, Craig Ryan Joseph in Handbook of Cancer and Immunology

  5. No Access

    Article

    Immune cell profiles in the tumor microenvironment of early-onset, intermediate-onset, and later-onset colorectal cancer

    Despite heightened interest in early-onset colorectal cancer (CRC) diagnosed before age 50, little is known on immune cell profiles of early-onset CRC. It also remains to be studied whether CRCs diagnosed at o...

    Tomotaka Ugai, Juha P. Väyrynen, Mai Chan Lau in Cancer Immunology, Immunotherapy (2022)

  6. Article

    Open Access

    An integrated analysis of lymphocytic reaction, tumour molecular characteristics and patient survival in colorectal cancer

    Histological lymphocytic reaction is regarded as an independent prognostic marker in colorectal cancer. Considering the lack of adequate statistical power, adjustment for selection bias and comprehensive tumou...

    Koichiro Haruki, Keisuke Kosumi, Peilong Li, Kota Arima in British Journal of Cancer (2020)